Immunovant Inc (IMVT) — Financial Flexibility Index
Immunovant Inc (IMVT) has a Financial Flexibility Index of -1.39x as of December 2025. Free cash flow of $-92.33 Million (operating CF $-92.33 Million minus capex $0.00) represents -1% of total liabilities ($66.26 Million). Also explore Immunovant Inc net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immunovant Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Immunovant Inc across 8 annual periods. Check Immunovant Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Immunovant Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Immunovant Inc. For the full company profile including market capitalisation, see market value of Immunovant Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.45x | $-375.12 Million | $-375.87 Million | $68.78 Million | ▼ -24.8% |
| 2024 | -4.37x | $-213.87 Million | $-214.23 Million | $48.95 Million | ▼ -0.7% |
| 2023 | -4.34x | $-188.00 Million | $-188.19 Million | $43.34 Million | ▼ -87.4% |
| 2022 | -2.31x | $-105.86 Million | $-106.11 Million | $45.74 Million | ▲ +41.5% |
| 2021 | -3.96x | $-83.12 Million | $-83.33 Million | $21.01 Million | ▼ -13.6% |
| 2020 | -3.48x | $-53.33 Million | $-53.36 Million | $15.32 Million | ▲ +95.4% |
| 2019 | -74.90x | $-28.50 Million | $-28.55 Million | $380.45K | ▲ +6.0% |
| 2018 | -79.66x | $-128.25 Million | $-128.30 Million | $1.61 Million | — |